BioIVT learned about the EMA's new Voluntary Data Submission program, which will provide participants with individual, non-binding, and non-decisional feedback on the regulatory relevance and readiness of their NAM or weight-of-evidence approach.
Published
Signal category
Research & Knowledge
Quote
“Selected participants for the EMA’s new Voluntary Data Submission will receive individual, non-binding, and non-decisional feedback on the regulatory relevance and readiness of their NAM or weight-of-evidence approach”
— Michael Millhollen|BioIVT team
Company
BioIVT
ELEVATING SCIENCE
- Industry
- Biotechnology Research
- Location
- Woodbury, US
- Company size
- 470 employees
BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. We specialize in control and disease state samples including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. Our Research Services team works collaboratively with clients to provide in vitro hepatic modeling solutions. And as the world’s premier supplier of ADME-Tox model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.
Founded 1981